巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

Co-Diagnostics

CODX
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・Co-Diagnostics - 延遲價格・最後更新於 14/01 12:14
最高位
8.910
最低位
8.610
開市價
--
前收市價
8.870
成交量(千)
20.52
成交額(百萬)
1.57
買入
--
賣出
--
每手股數
--
市值(百萬)
258.07
市盈率
6.190
息率
--
差價
--
52週高低
20.685 - 7.010
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
Co-Diagnostics
證券代碼
CODX.US
所屬板塊
Diagnostics & Research
公司業務
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.
發行量
28665714
公司總部
2401 South Foothill Drive
公司網址
http://www.codiagnostics.com
公司電話
+1 801 438-1036
暫無內容

關於

Co-Diagnostics(CODX.US)所屬的行業板塊為Diagnostics & Research。
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.
詳細公司背景可參考: http://www.codiagnostics.com